We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Not Achieving ‘Best-Case’ Projected Number of Inspections
FDA Not Achieving ‘Best-Case’ Projected Number of Inspections
As of mid-September, the FDA had conducted just 295 domestic and 44 foreign pharmaceutical inspections for fiscal year 2021, falling far short of its “best-case” scenario projections.